NCT05611814

Brief Summary

Motion sickness directly impacts the readiness of the Army's aviation units. Severe motion sickness results in the dismissal of pilot and air crew candidates during initial training, while minor to moderate symptoms can be distracting during flight. The current medications on the market that target motion sickness symptoms are prohibited for use before flight. Osteopathic Manipulative Techniques are a low to no cost option, which lacks side effects, that allows Doctor of Osteopathic Medicine flight surgeons the opportunity to treat crew members without the use of pharmaceuticals. If effective, these techniques could be used to ensure aircrew readiness. Given the paucity of research on such a technique, a small, pilot study was conducted to demonstrate potential for such an approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 24, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 1, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

Same day

First QC Date

November 1, 2022

Last Update Submit

November 7, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Motion sickness assessment questionnaire: gastrointestinal subscore from pre- to post-procedure

    The Motion Sickness Assessment Questionnaire is a valid and reliable measure of the four dimensions of motion sickness: gastrointestinal, central, peripheral, and sopite-related (Gianaros, et al., 2001). It includes 16 items and response format is a likert scale (1 to 9). The difference in scores from pre- to post-procedure were calculated.

    Administered immediately pre and post-procedure

  • Change in Motion sickness assessment questionnaire: central subscore from pre- to post-procedure

    The Motion Sickness Assessment Questionnaire is a valid and reliable measure of the four dimensions of motion sickness: gastrointestinal, central, peripheral, and sopite-related (Gianaros, et al., 2001). It includes 16 items and response format is a likert scale (1 to 9). The difference in scores from pre- to post-procedure were calculated.

    Administered immediately pre and post-procedure

  • Change in Motion sickness assessment questionnaire: peripheral subscore from pre- to post-procedure

    The Motion Sickness Assessment Questionnaire is a valid and reliable measure of the four dimensions of motion sickness: gastrointestinal, central, peripheral, and sopite-related (Gianaros, et al., 2001). It includes 16 items and response format is a likert scale (1 to 9). The difference in scores from pre- to post-procedure were calculated.

    Administered immediately pre and post-procedure

  • Change in Motion sickness assessment questionnaire: sopite-related subscore from pre- to post-procedure

    The Motion Sickness Assessment Questionnaire is a valid and reliable measure of the four dimensions of motion sickness: gastrointestinal, central, peripheral, and sopite-related (Gianaros, et al., 2001). It includes 16 items and response format is a likert scale (1 to 9). The difference in scores from pre- to post-procedure were calculated.

    Administered immediately pre and post-procedure

  • Change in Motion sickness assessment questionnaire: total subscore from pre- to post-procedure

    The Motion Sickness Assessment Questionnaire is a valid and reliable measure of the four dimensions of motion sickness: gastrointestinal, central, peripheral, and sopite-related (Gianaros, et al., 2001). It includes 16 items and response format is a likert scale (1 to 9). The difference in scores from pre- to post-procedure were calculated.

    Administered immediately pre and post-procedure

  • Heart rate variability

    Heart rate was aggregated in 30-second intervals. Coefficients of variance were then calculated across the twenty 30-second intervals per participant.

    Measured throughout procedure (10 minutes total)

Study Arms (2)

Sham treatment

SHAM COMPARATOR

The sham maneuver treatment addressed soft tissue tension, restriction of motion, and tenderness of the lower thoracic and lumbar regions.

Other: Sham treatment

Experimental Osteopathic Manipulative Treatment

EXPERIMENTAL

The sham maneuver treatment addressed soft tissue tension, restriction of motion, and tenderness of the cervical region (targeted anatomical structures).

Other: Osteopathic Manipulative Treatment

Interventions

Targeted anatomical structures are Scalene Muscles (Anterior/Middle/Posterior), Sternocleidomastoid Muscles (SCM), Suboccipital region, Cervical Paraspinal Muscles, Levator Scapulae Muscles, Upper Thoracic Paraspinal Muscles, Upper Trapezius Muscles, Atlanto-occipital (OA), Atlanto-axial (AA), C2-C7 vertebrae, T1-T4 vertebrae, Rib 1 bilaterally. Techniques include Suboccipital Myofascial Release, Soft tissue inhibition, kneading stretching, Facilitated Positional Release, and muscle energy technique.

Experimental Osteopathic Manipulative Treatment

Targeted anatomical structures are Thoracic Paraspinal Muscles, Lumbar Paraspinal Muscles, Lower Trapezius Muscles, Sacrum, Supraspinatus, T5-T12, and Rib 2-12. Techniques include Soft tissue inhibition, Stretching, Kneading, counterstrain, Facilitated Positional Release, and muscle energy technique. L1-L5

Sham treatment

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must have normal hearing, vision or corrected to normal vision, and cognitive function as determined by self-report and review on demographics and personal history questionnaire.
  • Must have obtained at minimum 6 hours of sleep prior to data collection, as assessed by self-report.
  • Must have refrained from consumption of alcohol and Medications that impact motion sickness symptoms for a minimum of 16 hours prior to each test session, assessed by self-report.

You may not qualify if:

  • Must not be currently taking any medications that may affect the vestibular system as assessed by self-report and at the discretion of the study physician.
  • Must not have a history of vestibular disorders as assessed by self-report.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

US Army Aeromedical Research Laboratory

Fort Rucker, Alabama, 36362, United States

Location

MeSH Terms

Conditions

Motion Sickness

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants received treatment in private room. Study team and participants were blind to group (treatment received). Only the treatment administrator knew which treatment each participant received and was excluded from the remainder of the protocol.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Between subjects design with two groups: sham and experimental (osteopathic manipulative treatment \[OMT\])
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Psychologist

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 10, 2022

Study Start

September 24, 2022

Primary Completion

September 24, 2022

Study Completion

September 24, 2022

Last Updated

November 10, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations